NEU 1.03% $19.30 neuren pharmaceuticals limited

bell potter research report - 12c target, page-178

  1. 853 Posts.
    lightbulb Created with Sketch. 16
    As far as I concern I take broker reports as a grain of salt. Note the conflict of interest when fees are payed by company to brokers, this is carefully disclosed in the report and by the company. I am not saying it's worth nothing, it definitely helps sentiment towards that stock but becareful how you extrapolate it. Esp. if the broker recommendation is not new. Good luck to all.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.